UNSPSC 51332879: Trifluoperazine dimaleate

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C21H24F3N3S.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AN9ZJ2YUI0, chemically known as phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, maleate (1:2), but more generally known as trifluoperazine dimaleate, which bears US NIH Compound Identifier 6438223.

European Medicines Agency schedules trifluoperazine dimaleate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11288MIG. Most nations, for tariff purposes, schedule trifluoperazine dimaleate under HS 29343090. SMILES: CN1CCN(CC1)CCCN2C3C(CCC(C3)C(F)(F)F)SC4C2CCCC4.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51332879 Trifluoperazine dimaleate is a Commodity code nominally identifying a specific antipsychotic pharmaceutical, but the single recent state and local opportunity posted under this code shows a significant mismatch: Seminole County, Florida's IFB60459723LAS solicits Naloxone and Safe Drug Deactivation Systems rather than trifluoperazine dimaleate. Naloxone is an opioid antagonist used in overdose response, not an antipsychotic. The code appears to capture little relevant recent activity aligned with its nominal scope. The Seminole County procurement does reflect health-department buying patterns — an issuing body with recurring pharmaceutical or medical-device needs — but the product actually being solicited falls outside the code's stated commodity definition.

Seminole County, Florida is the sole jurisdiction with recent documented activity under this code. The IFB posted on June 30, 2026, with a response deadline of July 26, 2023 (a date in the past relative to the posting), seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries an initial two-year term with a one-year renewal option and requires vendors to meet E-Verify compliance, drug-free workplace certification, and specified insurance coverages. The procurement does not designate set-asides for disadvantaged enterprises and may be FEMA-funded. The fundamental mismatch between the code's pharmaceutical scope and the naloxone procurement suggests either a tagging error in the state and local procurement system or a code that sees minimal activity aligned with its definition. A business development team should verify the correct UNSPSC classification before pursuing this category.